Scientists at the Georgia Institute of Technology have attained
very promising results on their initial investigations of a new
test for ovarian cancer. Using a new technique involving mass
spectrometry of a single drop of blood serum, the test correctly
identified women with ovarian cancer in 100 percent of the 94
patients tested. Because of the extremely low prevalence of
ovarian cancer in the general population (∼0.04%), extensive
prospective testing will be required to evaluate the test’s
potential utility in general screening applications. Scientists
at the Georgia Institute of Technology have attained very
promising results on their initial investigations of a new test
for ovarian cancer. Using a new technique involving mass
spectrometry of a single drop of blood serum, the test correctly
identified women with ovarian cancer in 100 percent of the 94
patients tested. The results can be found online in the journal
Cancer Epidemiology, Biomarkers, & Prevention Research. “Because
ovarian cancer is a disease